Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

Experimental Neurology

Volumn 197, Issue 2, 2006, Pages 284-290

  Lane, E L ^a,c   Cheetham, S C ^b   Jenner, P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b RenaSci Ltd   (United Kingdom)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Behaviour; L dopa; Monoamine reuptake inhibitor; Parkinson's disease

Indexed keywords

1 [1 (3,4 DICHLOROPHENYL)CYCLOBUTYL] 2 (3 DIAMINETHYLAMINOPROPYLTHIO)ETHANONE MONOCITRATE; ANTIPARKINSON AGENT; BTS 74398; LEVODOPA; MONOAMINE UPTAKE INHIBITOR; OXIDOPAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MOTOR DYSFUNCTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ADRENERGIC AGENTS; ANIMALS; BEHAVIOR, ANIMAL; CHLOROBENZENES; CYCLOBUTANES; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; DRUG INTERACTIONS; LEVODOPA; MALE; MODELS, BIOLOGICAL; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST; ROTATION; STEREOTYPED BEHAVIOR; TIME FACTORS;

EID: 30444449968     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.06.006     Document Type: Article

References (30)

1. E.D. Abercrombie, A.E. Bonatz, and M.J. Zigmond Effects of l-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats Brain Res. 525 1990 36 44
2. K.E. Asin, L. Bednarz, A. Nikkel, and R. Perner Rotation and striatal c-fos expression after repeated daily treatment with selective dopamine receptor agonists and levodopa J. Pharmacol. Exp. Ther. 273 1995 1483 1490
3. W. Bara-Jimenez, T. Dimitrova, A. Sherzai, A. Favit, M.M. Mouradian, and T.N. Chase Effect of monoamine reuptake inhibitor NS 2330 in advanced Parkinson's disease Mov. Disord. 19 2005 1183 1186
4. R. Camicioli, E. Lea, J.G. Nutt, G. Sexton, and B.S. Oken Methylphenidate increases the motor effects of l-Dopa in Parkinson's disease: a pilot study Clin. Neuropharmacol. 24 2001 208 213
5. R.J. Carey Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra Exp. Neurol. 92 1986 591 600
6. R.J. Carey Chronic l-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance Brain Res. 568 1991 205 214
7. M.A. Cenci, C.S. Lee, and A. Bjorklund l-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA Eur. J. Neurosci. 10 1998 2694 2706
8. B. Costall, D.M. Kelly, and R.J. Naylor Nomifensine: a potent dopaminergic agonist of antiparkinson potential Psychopharmacologia 41 1975 153 164
9. B. Costall, R.J. Naylor, and C. Pycock Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway Eur. J. Pharmacol. 35 1976 276 283
10. R.C. Duvoisin, R.E. Heikkila, and L. Manzino Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathway Neurology 32 1982 1387 1391
11. S. Fahn, L.R. Libsch, and R.W. Cutler Monoamines in the human neostriatum: topographic distribution in normals and in Parkinson's disease and their role in akinesia, rigidity, chorea, and tremor J. Neurol. Sci. 14 1971 427 455
12. M.J. Hansard, L.A. Smith, M.J. Jackson, S. Cheetham, and P. Jenner The antiparkinsonian ability of buproprion in MPTP-treated common marmosets Br. J. Pharmacol. 125 1999 (suppl, 66 pp.)
13. M.J. Hansard, L.A. Smith, M.J. Jackson, S.C. Cheetham, and P. Jenner Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates J. Pharmacol. Exp. Ther. 303 2002 952 958
14. M.J. Hansard, L.A. Smith, M.J. Jackson, S. Cheetham, and P. Jenner The monoamine reuptake inhibitor BTS 74398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates Mov. Disord. 19 2004 15 21
15. R.E. Heikkila, F.S. Cabbat, L. Manzino, and R.C. Duvoisin Potentiation by deprenil of l-dopa induced circling in nigral-lesioned rats Pharmacol. Biochem. Behav. 15 1981 75 79
16. P. Jenner Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease Curr. Opin. Neurol. 16 Suppl. 1 2003 S3 S7
17. E.L. Lane, S.C. Cheetham, and P. Jenner Repeated administration of the monoamine reuptake inhibitor BTS 74 398 induces ipsilateral circling in the 6-hydroxydopamine lesioned rat without sensitising motor behaviours Eur. J. Neurosci. 21 2005 179 186
18. M. Lundblad, M. Andersson, C. Winkler, D. Kirik, N. Wierup, and MA. Cenci Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease Eur. J. Neurosci. 15 2002 120 132
19. D.W. Miller, and E.D. Abercrombie Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous l-dopa: studies in intact and 6-hydroxydopamine-treated rats J. Neurochem. 74 1999 1516 1522
20. S.M. Papa, T.M. Engber, A.M. Kask, and T.N. Chase Motor fluctuations in levodopa treated parkinsonian rats: relation to lesion extent and treatment duration Brain Res. 662 1994 69 74
21. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 1987 Academic Press New York
22. A. Prikhojan, T. Brannan, and M.D. Yahr Comparative effects of repeated administration of dopamine agonists on circling behaviour in rats J. Neural Transm. 107 2000 1159 1164
23. M.B. Schneider, L.C. Murrin, R.F. Pfeiffer, and J.D. Deupree Dopamine receptors: effects of chronic l-dopa and bromocriptine treatment in an animal model of Parkinson's disease Clin. Neuropharmacol. 7 1984 247 257
24. R.K. Schwarting, and J.P. Huston The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments Prog. Neurobiol. 50 1996 275 331
25. R.K. Schwarting, A.E. Bonatz, R.J. Carey, and J.P. Huston Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections Brain Res. 554 1991 46 55
26. U. Ungerstedt Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour Acta Physiol. Scand., Suppl. 367 1971 49 68
27. U. Ungerstedt, and G.W. Arbuthnott Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system Brain Res. 24 1970 485 493
28. T. Zetterstrom, M. Herrera-Marschitz, and U. Ungerstedt Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis Brain Res. 376 1986 1 7
29. M. Ziegler, and H. Szechtman Differences in the behavioral profile of circling under amphetamine and apomorphine in rats with unilateral lesions of the substantia nigra Behav. Neurosci. 102 1988 276 288
30. M.G. Ziegler, and H. Szechtman Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system Behav. Brain Res. 39 1990 123 133